Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Walgreens Boots Alliance Inc. tumbled Friday after suspending the quarterly dividend it’s paid for the past 92 years in a bid ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...

Walgreens suspends its quarterly dividend for the first time in 92 years as it faces challenges in its financial turnaround effort.

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

Walgreens Boots Alliance Inc. is suspending the quarterly dividend it’s paid for the past 92 years in a worrying sign for the ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...